The forecasted sales of obstructive airway diseases medicine in Germany indicate a steady increase from 2024 to 2028: $32.9, $33.6, $34.2, $34.9, and $35.5 per capita, respectively. This upward trend suggests a consistent annual growth rate in medicine sales for this segment. With the stabilization initiated from a base in 2023, these figures reflect a gradual, but predictable enhancement.
Future trends to watch for include:
- Innovation in treatment methods and drug formulations.
- Impact of demographic changes and aging population on medicine demand.
- Potential pricing pressures from regulatory interventions and cost-containment policies.
- Advancements in personalized medicine driven by technological innovations.
